Search - tctmd.com

Displaying 881 - 900 of 2514

Sort: Relevancy | Date

Presentation TCT 2022

TCT 726: Novel use of shockwave Lithotripsy at the distal abdominal aorta to facilitate transcatheter aortic valve implantation

Presenter: Yashwant Agrawal

September 18, 2022

Presentation TCT 2022

TCT 626: Facilitated Transcaval Access by Shockwave Lithoplasty and Conscious Sedation for Transcatheter Aortic Valve Replacement

Presenter: José Antonio Baz Alonso

September 18, 2022

Presentation TCT 2022

Keynote Lecture: Unexpected Coronary Obstruction Post-TAVR: Diagnostic Assessment and Therapeutic Options

Presenter: Neal Kleiman

September 18, 2022

Presentation TCT 2022

SavvyWire: Additional Applications

Presenter: Anita Asgar

September 18, 2022

Presentation TCT 2022

OpSens SavvyWire: Device Review & Case Example

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Minimalist TAVR: Optimizing Outcomes without Compromise

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

Why are Hemodynamics so Important During TAVR?

Presenter: David Wood

September 18, 2022

Presentation TCT 2022

Contemporary Trends in Aortic Stenosis Management

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2022

New and Novel CEP Devices: Differentiating Features

Presenter: Giora Weisz

September 17, 2022

Presentation TCT 2022

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presenter: David J. Cohen

September 17, 2022

Presentation TCT 2022

Selective Use: Only in Vulnerable Patients

Presenter: John K. Forrest

September 17, 2022

Presentation TCT 2022

Systematic Use: Unravelling the Stroke Story

Presenter: Nicolas M. Van Mieghem

September 17, 2022

Presentation TCT 2022

The British Heart Foundation PROTECT TAVI Trial: The Next Round!

Presenter: Daniel J. Blackman

September 17, 2022

Presentation TCT 2022

Other Registry Findings and PROTECTED TAVR: Concordant or Divergent

Presenter: Raj Makkar

September 17, 2022

Presentation TCT 2022

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

Presenter: Axel Linke

September 17, 2022

Presentation TCT 2022

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

Presenter: Steven Messe

September 17, 2022

Presentation TCT 2022

TCT 400: Impact of Initial Valve Type on Outcomes after Reintervention for TAVR Failure: Insights from the EXPLANTORREDO-TAVR International Registry

Presenter: Syed Zaid

September 17, 2022

Presentation TCT 2022

PROTECTED TAVR: My Take-Home Messages & Some "Dirty Little Secrets"

Presenter: Samir Kapadia

September 17, 2022

Presentation TCT 2022

TCT 399: Impact of Mechanism of TAVR failure on Outcomes after Reintervention for Failed TAVR: Insights from the EXPLANTORREDO-TAVR International Registry

Presenter: Syed Zaid

September 17, 2022

Advertisement

TCT 726: Novel use of shockwave Lithotripsy at the distal abdominal aorta to facilitate transcatheter aortic valve implantation

TCT 626: Facilitated Transcaval Access by Shockwave Lithoplasty and Conscious Sedation for Transcatheter Aortic Valve Replacement

Keynote Lecture: Unexpected Coronary Obstruction Post-TAVR: Diagnostic Assessment and Therapeutic Options

SavvyWire: Additional Applications

OpSens SavvyWire: Device Review & Case Example

Minimalist TAVR: Optimizing Outcomes without Compromise

Why are Hemodynamics so Important During TAVR?

Contemporary Trends in Aortic Stenosis Management

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

New and Novel CEP Devices: Differentiating Features

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Selective Use: Only in Vulnerable Patients

Systematic Use: Unravelling the Stroke Story

The British Heart Foundation PROTECT TAVI Trial: The Next Round!

Other Registry Findings and PROTECTED TAVR: Concordant or Divergent

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

TCT 400: Impact of Initial Valve Type on Outcomes after Reintervention for TAVR Failure: Insights from the EXPLANTORREDO-TAVR International Registry

PROTECTED TAVR: My Take-Home Messages & Some "Dirty Little Secrets"

TCT 399: Impact of Mechanism of TAVR failure on Outcomes after Reintervention for Failed TAVR: Insights from the EXPLANTORREDO-TAVR International Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content